John Laterra Selected Research

John Laterra Research Topics

Disease

71	Neoplasms (Cancer) 05/2022 - 01/2002
30	Glioblastoma (Glioblastoma Multiforme) 05/2022 - 04/2002
30	Glioma (Gliomas) 11/2021 - 01/2002
19	Brain Neoplasms (Brain Tumor) 01/2022 - 12/2003
8	Medulloblastoma 09/2010 - 10/2005
5	Carcinogenesis 01/2022 - 05/2004
5	Neoplasm Metastasis (Metastasis) 05/2016 - 06/2003
4	Gliosarcoma 04/2011 - 12/2003
3	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 12/2005
3	Necrosis 03/2012 - 06/2008
2	Hemorrhage 06/2017 - 05/2004
2	Breast Neoplasms (Breast Cancer) 01/2011 - 09/2003
2	Melanoma (Melanoma, Malignant) 01/2011 - 12/2005
2	Colonic Neoplasms (Colon Cancer) 10/2008 - 06/2003
2	Infarction (Infarctions) 06/2006 - 04/2004
2	Hypoxia (Hypoxemia) 06/2006 - 04/2004
2	Central Nervous System Neoplasms 02/2006 - 10/2005
1	Fever (Fevers) 05/2020
1	Cytopenia 05/2020
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 05/2020
1	Vascular Malformations 06/2017

Drug/Important Bio-Agent (IBA)

21	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 04/2013 - 01/2002
18	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2003
10	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2014 - 06/2003
9	AmidesIBA 01/2022 - 12/2003
9	Protons (Proton)IBA 01/2022 - 12/2003
9	Monoclonal AntibodiesIBA 02/2016 - 02/2006
8	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 12/2005
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2002
7	Transcription Factors (Transcription Factor)IBA 01/2020 - 02/2008
7	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2010 - 01/2002
6	APTIBA 01/2022 - 12/2003
6	Phosphotransferases (Kinase)IBA 04/2016 - 12/2004
5	Small Interfering RNA (siRNA)IBA 01/2022 - 04/2010
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2009
5	EnzymesIBA 05/2021 - 01/2002
5	Messenger RNA (mRNA)IBA 04/2010 - 04/2004
5	Catalytic RNA (Ribozymes)IBA 06/2005 - 01/2002
4	MicroRNAs (MicroRNA)IBA 06/2021 - 07/2015
4	GadoliniumIBA 11/2019 - 10/2008
4	LigandsIBA 07/2009 - 02/2004
3	Biological ProductsIBA 11/2021 - 06/2003
3	TenascinIBA 01/2019 - 04/2016
3	Peptides (Polypeptides)IBA 08/2012 - 12/2003
3	CamptothecinIBA 10/2009 - 06/2005
3	Death Domain ReceptorsIBA 10/2009 - 08/2007
2	Uridine Diphosphate (UDP)IBA 05/2022 - 01/2018
2	CytokinesIBA 01/2022 - 10/2021
2	Temozolomide (Temodar)FDA LinkGeneric 11/2021 - 03/2009
2	Pharmaceutical PreparationsIBA 05/2021 - 10/2007
2	Fatty Acids (Saturated Fatty Acids)IBA 05/2021 - 12/2009
2	Extracellular Matrix ProteinsIBA 01/2019 - 01/2018
2	Contrast MediaIBA 01/2019 - 12/2015
2	Histones (Histone)IBA 10/2018 - 07/2009
2	Histone Deacetylase InhibitorsIBA 10/2018 - 06/2012
2	IntegrinsIBA 03/2016 - 11/2014
2	Ligases (Synthetase)IBA 06/2014 - 12/2009
2	Acyl Coenzyme A (Acyl CoA)IBA 06/2014 - 12/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2009 - 06/2005
2	fas Receptor (CD95 Antigen)IBA 10/2009 - 06/2005
2	HhAntag691IBA 09/2009 - 01/2009
2	Adenosine Triphosphate (ATP)IBA 07/2009 - 12/2005
2	Mitogen-Activated Protein KinasesIBA 07/2009 - 10/2005
2	ErbB Receptors (EGF Receptor)IBA 07/2009 - 01/2008
2	Epidermal Growth Factor (EGF)IBA 07/2009 - 01/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2008 - 08/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2005 - 05/2004
2	tyrosine receptor (receptor, tyrosine)IBA 06/2005 - 12/2004
1	Interleukin-33IBA 01/2022
1	ChemokinesIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Doxycycline (Periostat)FDA LinkGeneric 01/2022
1	A-Form DNA (A-DNA)IBA 11/2021
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2021
1	long-chain-fatty-acid-CoA ligaseIBA 05/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 05/2021
1	SphingolipidsIBA 05/2021
1	osimertinibIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 05/2020
1	PyrrolesIBA 05/2020
1	AntagomirsIBA 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2019
1	3-O-Methylglucose (3 O Methylglucose)IBA 01/2019
1	Sirolimus (Rapamycin)FDA Link 01/2019
1	EstersIBA 11/2018
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 10/2018
1	PanobinostatIBA 10/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2018
1	BrevicanIBA 01/2018
1	Investigational DrugsIBA 08/2016
1	TetraspaninsIBA 03/2016

Therapy/Procedure

31	Therapeutics 01/2022 - 04/2004
4	Drug Therapy (Chemotherapy) 10/2018 - 06/2005
2	Immunomodulation 10/2021 - 01/2019
2	Intravenous Injections 01/2019 - 01/2002
2	Craniotomy 06/2017 - 01/2010
2	Radiotherapy 06/2014 - 03/2009
1	Aftercare (After-Treatment) 01/2019
1	Neurosurgical Procedures 01/2017
1	Immunotherapy 08/2016